NYU Lung Cancer Biomarker Center is recruiting subjects over 50 for lung cancer clinical trial

The NYU Lung Cancer Biomarker Center is funded by the National Cancer Institute's Early Detection Research Network, plus a contribution from Con Edison. The purpose of the study is to identify and validate biomarkers for the early detection of lung cancer. The study conducts lung cancer screening of patients at high-risk for lung cancer and follows patients with possible or confirmed lung cancer diagnoses.

There have been over 2,000 subjects enrolled in the study since it began in 2001. Current or former smokers with at least 20 pack years and without any previous history of cancer (except non melanoma skin cancer) are eligible. In some cases non-smokers and those with occupational asbestos exposure may also be eligible to participate.

The initial screening visit takes about 2 hours and involves questionnaire, breathing test, sputum collection and blood draw (for research purposes) and a spiral low dose CT scan of the chest. The initial CT scan is paid for by the study. Clinically indicated follow-up CT scans require health insurance.

For more information or to schedule an appointment please call Ellen Eylers, RN, 212-263-6126 or Jackie Correa, 212-263-6103. Email contact: Ellen Eylers and Jackie Correa